Phase I study of bevacizumab, everolimus, and panobinostat (LBH-589) in advanced solid tumors
Titel:
Phase I study of bevacizumab, everolimus, and panobinostat (LBH-589) in advanced solid tumors
Auteur:
Strickler, John H. Starodub, Alexander N. Jia, Jingquan Meadows, Kellen L. Nixon, Andrew B. Dellinger, Andrew Morse, Michael A. Uronis, Hope E. Marcom, P. Kelly Zafar, S. Yousuf Haley, Sherri T. Hurwitz, Herbert I.